Please check your internet connection and try again.
# Isoxsuprine hydrochloride
## Overview
Isoxsuprine is a beta-adrenergic agonist with vasodilatory properties. It acts as a peripheral vasodilator by stimulating beta-2 receptors in vascular smooth muscle. Its use in modern clinical practice is limited as more effective, evidence-based alternatives are available.
## Primary Indications
* Cerebral vascular insufficiency (provisional/historically).
* Peripheral vascular disease (e.g., arteriosclerosis obliterans, Buerger's disease, Raynaud's phenomenon).
* Historically used off-label for premature labor (tocolysis), but this use is no longer standard due to lack of efficacy and safety concerns regarding maternal cardiovascular events.
## Adult Dosing
* **Peripheral Vascular Disease:** 10 mg to 20 mg orally 3 to 4 times daily.
* **Maximum Dosage:** Generally considered 80 mg/day (4 doses of 20 mg).
* *Note: Dosing varies by local protocol and national regulatory approval; consult institutional guidelines.*
## Pediatric Dosing
* **Safety/Efficacy:** Not established. Use is generally not recommended in pediatric populations.
## Dose Adjustments
* **Renal/Hepatic Impairment:** No specific manufacturer guidelines provided. Use with extreme caution; titrate conservatively if clinical necessity exists.
## Contraindications
* Hypersensitivity to isoxsuprine.
* Immediate postpartum period (due to theoretical risk of uterine hemorrhage).
* In the presence of arterial bleeding.
* Severe hypotension, tachycardia, or recent myocardial infarction.
## Adverse Effects
* **Common:** Hypotension, tachycardia, dizziness, flushing, palpitations.
* **Gastrointestinal:** Nausea, vomiting, abdominal distress.
* **Neurological:** Tremor, nervousness, weakness.
* **Rare:** Severe maternal cardiovascular events (if used off-label for tocolysis, including pulmonary edema and cardiac arrest).
## Key Drug Interactions
* **Other Vasodilators/Antihypertensives:** Potential for additive hypotensive effects.
* **Beta-Blockers:** May antagonize the pharmacological action of isoxsuprine.
* **Sympathomimetics:** May lead to additive cardiovascular stimulation.
## Monitoring
* **Blood Pressure:** Monitor frequently, especially during initial therapy.
* **Heart Rate:** Monitor for tachycardia/palpitations.
* **Symptoms:** Assess for resolution of peripheral claudication or vascular symptoms.
## Clinical Pearls
* **Evidence Status:** The clinical utility of isoxsuprine for most indications is highly debated, and it has been withdrawn from some markets due to lack of verified efficacy.
* **Patient Counseling:** Advise patients to rise slowly from a sitting or lying position to mitigate orthostatic hypotension.
* **Pregnancy Usage:** Do not use for tocolysis; it is contraindicated in obstetric settings where uterine bleeding may occur.
***
**Educational Disclaimer:** This information is intended for educational purposes for healthcare professionals and does not constitute medical advice. Dosing, contraindications, and clinical practices may vary by region and institutional policy. Always verify prescribing information against current local formularies and official product monographs before prescribing or administering any medication.
